biotech / news / / MarketScreener
GSK reports on a US court ruling in ongoing litigation.
GSK's Tesaro had its anticipatory breach claim dismissed, but its main dispute with AnaptysBio continues.
KEY POINTS
- AstraZeneca's Saphnelo is now FDA-approved in the US for self-administration via autoinjector in lupus treatment.
- Harworth Group secured planning approval for a 500,000-square-foot Microsoft-linked hyperscale data centre in Leeds.
- Kelso Group now holds a new stake in Filtronic, which has tripled revenue and 90% of FY2026 covered.
COMPANIES
Summarized by Newsio from MarketScreener. How we summarize →